Cheng Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cheng Zhao has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Xiaojuan Zhang
Department of Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, China
2 shared publicationsDandan Jiang
Department of Breast Surgery, the affiliated hospital of Qingdao University, Qingdao, China
1 shared publicationDanni Jiang
Department of Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, China
1 shared publication- Hongwei Xue
Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China
1 shared publication Lei Xin
Affiliated Hospital of Qingdao University, Qingdao, China
1 shared publication- Qinqin Wang
Department of Ultrasound, The Affiliated Hospital of Qingdao University, China
1 shared publication
Latest Publications
- Open Access
- 21 November 2018
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 47 (2) , 626-634
Value of rapid on-site evaluation for ultrasound-guided thyroid fine needle aspiration
Objective: Application of rapid on-site evaluation (ROSE) for thyroid fine needle aspiration (FNA) is controversial. Therefore, ROSE has not been universally applied. This study aimed to evaluate the value of ROSE for ultrasound-guided thyroid FNA. Methods: A total of 997 patients with 1103 suspicious thyroid nodules had ultrasound-guided FNA performed from January 2016 to February 2018. There were 513 nodules with ROSE and 590 nodules without ROSE. The cytological nondiagnostic rate, needle passes, and procedural times of thyroid FNA with or without ROSE were compared. The nondiagnostic rates of subsets of suspicious thyroid nodules were further compared. Results: There was no significant effect of ROSE on the nondiagnostic rate of FNA. However, FNA with ROSE significantly reduced the numbers of sub-centimeter, mixed solid-cystic, macrocalcified, and hypervascular nodules. There was a significantly smaller number of needle passes and less procedural times with ROSE than without ROSE. There was no significant difference in the complication rate of FNA with and without ROSE. Conclusion: ROSE for thyroid FNA reduces the number of needle passes and procedural times. ROSE has a higher clinical application value in subsets of thyroid nodules, which tend to be difficult to diagnose with FNA.
- 21 November 2018
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 47 (2) , 626-634
Open AccessValue of rapid on-site evaluation for ultrasound-guided thyroid fine needle aspiration
Objective: Application of rapid on-site evaluation (ROSE) for thyroid fine needle aspiration (FNA) is controversial. Therefore, ROSE has not been universally applied. This study aimed to evaluate the value of ROSE for ultrasound-guided thyroid FNA. Methods: A total of 997 patients with 1103 suspicious thyroid nodules had ultrasound-guided FNA performed from January 2016 to February 2018. There were 513 nodules with ROSE and 590 nodules without ROSE. The cytological nondiagnostic rate, needle passes, and procedural times of thyroid FNA with or without ROSE were compared. The nondiagnostic rates of subsets of suspicious thyroid nodules were further compared. Results: There was no significant effect of ROSE on the nondiagnostic rate of FNA. However, FNA with ROSE significantly reduced the numbers of sub-centimeter, mixed solid-cystic, macrocalcified, and hypervascular nodules. There was a significantly smaller number of needle passes and less procedural times with ROSE than without ROSE. There was no significant difference in the complication rate of FNA with and without ROSE. Conclusion: ROSE for thyroid FNA reduces the number of needle passes and procedural times. ROSE has a higher clinical application value in subsets of thyroid nodules, which tend to be difficult to diagnose with FNA.
- 1 February 2018
- Published by Elsevier in European Journal of Radiology
- Vol. 99, 88-93
Value of contrast-enhanced ultrasound and PET/CT in assessment of extramedullary lymphoma
- 1 February 2018
- Published by Elsevier in European Journal of Radiology
- Vol. 99, 88-93
Value of contrast-enhanced ultrasound and PET/CT in assessment of extramedullary lymphoma
- Open Access
- 23 May 2017
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 45 (3) , 1221-1230
Risk factors for lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC): role of preoperative ultrasound
Objective: This study aimed to investigate the risk factors and clinical value of lymph node metastasis (LNM) and missed central lymph node metastasis (CLNM) using preoperative ultrasound (US) in patients with papillary thyroid microcarcinoma (PTMC). Methods: This retrospective study included 521 patients who underwent thyroidectomy for confirmed PTMC based on a final histological examination between January 2014 and June 2015. Based on the presence of LNM, 521 cases were divided into two groups: metastasis (218) and non-metastasis (303). Univariate and multivariate logistic regression analyses were used to analyse the US and clinical characteristics of the primary tumour. Results: We defined LNM based on the tumour diameter with an optimal critical value of 0.55 cm using ROC analysis with a sensitivity of 65.6% and specificity of 59.6%. We defined US-missed CLNM based on the optimal critical value of 0.65 cm using diagnostic ROC analysis with a sensitivity of 66.0% and specificity of 73.0%. The odds ratios of significant factors with LNM by US were 10.3 (95% confidence interval [95% CI], 6.2–17.0), 5.3 (95% CI, 3.3–8.7), 2.7 (95% CI, 1.1–6.5), 4.3 (95% CI, 1.7–10.5), 2.5 (95% CI, 1.5–4.1), and 2.7 (95% CI, 1.7–4.4) for extrathyroidal invasion, blood flow, multifocality, tumour diameter greater than 0.55 cm, male sex, and age younger than 47 years, respectively. Conclusions: US characteristics, such as extrathyroidal invasion, blood flow, tumour diameter, sex, and age, may improve the efficacy of predicting LNM and facilitating diagnosis of PTMC. Furthermore, tumour invasion to the extracapsular thyroid and a diameter greater than 0.65 cm indicate CLNM.
- 23 May 2017
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 45 (3) , 1221-1230
Open AccessRisk factors for lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC): role of preoperative ultrasound
Objective: This study aimed to investigate the risk factors and clinical value of lymph node metastasis (LNM) and missed central lymph node metastasis (CLNM) using preoperative ultrasound (US) in patients with papillary thyroid microcarcinoma (PTMC). Methods: This retrospective study included 521 patients who underwent thyroidectomy for confirmed PTMC based on a final histological examination between January 2014 and June 2015. Based on the presence of LNM, 521 cases were divided into two groups: metastasis (218) and non-metastasis (303). Univariate and multivariate logistic regression analyses were used to analyse the US and clinical characteristics of the primary tumour. Results: We defined LNM based on the tumour diameter with an optimal critical value of 0.55 cm using ROC analysis with a sensitivity of 65.6% and specificity of 59.6%. We defined US-missed CLNM based on the optimal critical value of 0.65 cm using diagnostic ROC analysis with a sensitivity of 66.0% and specificity of 73.0%. The odds ratios of significant factors with LNM by US were 10.3 (95% confidence interval [95% CI], 6.2–17.0), 5.3 (95% CI, 3.3–8.7), 2.7 (95% CI, 1.1–6.5), 4.3 (95% CI, 1.7–10.5), 2.5 (95% CI, 1.5–4.1), and 2.7 (95% CI, 1.7–4.4) for extrathyroidal invasion, blood flow, multifocality, tumour diameter greater than 0.55 cm, male sex, and age younger than 47 years, respectively. Conclusions: US characteristics, such as extrathyroidal invasion, blood flow, tumour diameter, sex, and age, may improve the efficacy of predicting LNM and facilitating diagnosis of PTMC. Furthermore, tumour invasion to the extracapsular thyroid and a diameter greater than 0.65 cm indicate CLNM.